IHAM
TXG icon

Integral Health Asset Management’s 10x Genomics TXG Stock Holding History

Integral Health Asset Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-40,000
Closed -$2.49M – 77
2020
Q1 		$2.49M Buy
40,000
+15,000
+60% +$1.17M 1.1% 37
2019
Q4 		$1.91M Buy
+25,000
New +$1.5M 0.74% 39

Other funds holding TXG

VMV
Venrock Management VI Palo Alto, California $47.6M AUM 45.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCMI
Foresite Capital Management I Larkspur, California $21.4M AUM 80.48% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

Integral Health Asset Management's TXG Position: Q2 2020 in Review

Integral Health Asset Management sold out of 10x Genomics (TXG) in Q2 2020, closing a stake of 40,000 shares — an estimated $2.49M sold.

Integral Health Asset Management first reported a position in TXG in Q4 2019 and held it in 2 quarters. The position peaked at $2.49M in Q1 2020. 146 funds tracked by Wall St. Rank hold TXG as of Q2 2020.

  • Integral Health Asset Management reported no remaining 10x Genomics position as of Q2 2020 after selling out during the quarter.
  • Integral Health Asset Management sold 40,000 10x Genomics shares in Q2 2020, an estimated $2.49M.
  • Integral Health Asset Management first reported a position in 10x Genomics in Q4 2019 and held it in 2 quarters.
  • Integral Health Asset Management's 10x Genomics position peaked at $2.49M in Q1 2020.
  • 146 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2020.

Based on Integral Health Asset Management's 13F filing for Q2 2020, filed 14 Aug 2020.